Can-Fite Announces Late-Breaking Abstract Presentation on Namodenoson(TM) Phase II Results at the American Association of Clinical Oncology (ASCO) Annual Meeting

Press/Media

Period10 Apr 2019

Media coverage

1

Media coverage

  • TitleCan-Fite Announces Late-Breaking Abstract Presentation on Namodenoson(TM) Phase II Results at the American Association of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date10/04/19
    PersonsJosep Llovet